false 00000 0001499785 0001499785 2023-11-16 2023-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

Date of Report (date of earliest event reported): November 16, 2023

 

Tengjun Biotechnology Corp.

(Exact name of registrant as specified in its charter)

 

Nevada   333-169397   27-3042462
(State or other jurisdiction   (Commission File Number)   (I.R.S. Employer
of incorporation)       Identification Number)

 

East Jinze Road and South Huimin Road, Food Industry Economic and Technology Development District,

Jinxiang County, Jining City, Shandong Province, China

(Address of principal executive offices and zip code)

 

(86) 0537-8711599

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol(s)   Name of each exchange on which registered:
None   None   None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective as of November 16, 2023, Ruiming Zhou resigned from his position as a member of the Board of Directors (the “Board”), the CEO and CFO of Tengjun Biotechnology Corp (the “Company”). Mr. Zhou’s resignation was not a result of any disagreements with the Company on any matter relating to its operations, policies or practices.

 

Effective as of November 16, 2023, the Board appointed Qingbao Wang as a member of the Board, the CEO and CFO of the Company, until the next annual meeting of the Company’s stockholders, and until his successor is elected and qualified or until his prior death, resignation or removal.

 

Mr. Qingbao Wang, age 49, has been served as a director of Shandong Hawei Food Co., Ltd since June 2000. He graduated from Shaanxi University of Finance and Economics with a technical secondary school degree. Mr. Wang is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Mr. Wang and any other persons pursuant to which he was appointed as Director and executive officer of the Company.

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunder duly authorized.

 

Date: November 17, 2023    
     
  Tengjun Biotechnology Corp.
   
  By: /s/ Qingbao Wang
    Qingbao Wang
    Chief Executive Officer

 

 

2

 

 

v3.23.3
Cover
Nov. 16, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 16, 2023
Entity File Number 333-169397
Entity Registrant Name Tengjun Biotechnology Corp.
Entity Central Index Key 0001499785
Entity Tax Identification Number 27-3042462
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One East Jinze Road and South Huimin Road
Entity Address, Address Line Two Food Industry Economic and Technology Development District
Entity Address, Address Line Three Jinxiang County
Entity Address, City or Town Jining City
Entity Address, Country CN
Entity Address, Postal Zip Code 00000
City Area Code 0537
Local Phone Number 8711599
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Tengjun Biotechnology (CE) (USOTC:TJBH)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024 Haga Click aquí para más Gráficas Tengjun Biotechnology (CE).
Tengjun Biotechnology (CE) (USOTC:TJBH)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024 Haga Click aquí para más Gráficas Tengjun Biotechnology (CE).